The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

Laura Schober is a writer and editor specializing in health, food, wellness, beauty, and lifestyle content. Laura is also a seasoned communications professional who has previously worked in the ...

Needle-Free Growth Hormone Support via Telehealth - Platform Analysis Compares Compounded Prescription Tablets vs. Injectable ...

Secretary Robert F. Kennedy Jr. announced Thursday that the U.S. Department of Health and Human Services is taking six steps to push back against what he described as "sex-rejecting" transgender ...

Anabolic steroids can cause serious health risks, including heart attacks, strokes, reduced fertility, hardening of the arteries, liver damage, the development of male characteristics in women (such ...

Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H.

Learn more about eLife assessments Blood flow to the brain is a sensitive marker of neuronal activity as well as of a number of diseases, including stroke, tumours and neurodegenerative conditions.

But new research suggests that a simple blood test may be able to predict osteoporosis risk, allowing doctors to intervene ...

Compare whole milk and 2% milk by nutrients, taste, and health benefits, and find out which option may best support your lifestyle, preferences, and health goals.

Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...

When I was about 6 years old in the early ‘40s, my 16-year-old brother was sent to a sanitarium for tuberculosis patients. He ...